Rapid development of an updated mRNA vaccine against the SARS-CoV-2 Omicron variant.

ABSTRACT:

SUBMITTER: Zhang NN 

PROVIDER: S-EPMC8853430 | biostudies-literature | 2022 Apr

REPOSITORIES: biostudies-literature